June 8 - BioMarin’s valoctocogene roxaparvovec Hemophilia A Clinical Development Program
June 1 - Kogenate FS Discontinuation
May 17 - Comorbidities, Health-Related Quality of Life, Health-care Utilization in Older Persons with Hemophilia
May 10 - Women's health articles from HEMAWARE, the bleeding disorders magazine produced by NHF.
April 26 - Roctavian’s Effectiveness Tied to Molecules that Aid FVIII Production
March 23 - Low Red Blood Cells, Clotting Factor Levels Tied to Surgery Bleeding Risk
March 8 - Researchers secure $12 million grant to develop improved therapies for hemophilia
March 7 - The CDC recently released updated statistics about hemophilia characteristics among women and girls receiving care at specialized Hemophilia Treatment Centers (HTCs) in the United States.
February 7 - Update regarding BioMarin’s ongoing Phase 3 hemophilia A gene therapy study.
January 24 - Preventive Esperoct Plus Surgery Reduces Joint Bleeds, Aids Mobility
November 1 – Performing serial MRIs in young patients with hemophilia may spot early joint damage
October 21 - CDC director weighs in on trick-or-treating amid the pandemic
October 18- Reverse Vaccination’ May Help Prevent Immune Response
September 29 - Treatment prevents development of antibodies against drugs for hemophilia A and Pompe disease.
September 14 - SerpinPC, for Hemophilia A and B, Safely Prevents Bleeds in Phase 2a Trial
August 30 - The New Frontier of Hemophilia Treatment - Specialty Pharmacy Continuum
August 23 - Continuing Prophylaxis into Young Adulthood Improves Outcomes for Patients with Hemophilia
August 12 - National Vaccination Awareness Month: Chronic Conditions & Immunizations – BioMatrix Abstract
August 1: Manual Therapy Improves Joint Health in Hemophilia Patients